Related Experiment Video
Updated: May 23, 2026

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Characterization of patients with low baseline impedance on multichannel intraluminal impedance-pH reflux testing
Richard Heard1, June Castell, Donald O Castell
1Division of Gastroenterology and Hepatology, Digestive Disease Center, Medical University of South Carolina, Charleston, SC 29425, USA. richardkirkseyheard@gmail.com
Goals:
We aim to look at the prevalence of multichannel intraluminal impedance-pH (MII-pH) studies, which are difficult to interpret secondary to low distal baseline impedance (DBI), and characterize them by their respective diagnosis and DBI.
Background:
Some patients exhibit low DBI because of fluid retention in the esophagus or acute or chronic mucosal changes. Low DBI can make MII-pH difficult to interpret.
Study:
We reviewed MII-pH reports from patients studied from January 2002 to December 2009. We conducted a computerized search of the final interpretation for the terms "low," "low baseline," "difficult," and "unable." Reflux reports stating difficult or unable to interpret were analyzed. The associated manometry studies were reviewed to obtain the DBI (mean value at 5 and 10 cm above the lower esophageal sphincter in the pretest esophageal resting state).
Results:
Of 2809 MII-pH tracings, 38 (1.4%) were classified as difficult to interpret because of low DBI. The most common underlying manometric diagnosis was ineffective esophageal motility at 36.8%, followed by 28.9% with achalasia, and 10.5% with scleroderma esophagus. An additional 15.8% of patients had increased gastroesophageal reflux on MII-pH. In only 7.9% of patients was no obvious reason for the low DBI identified. Of the 38 patients, 92% had a DBI <1000 Ω, and 58% had a DBI <500 Ω.
Conclusions:
These findings indicate that difficulty in interpreting MII-pH due to low baseline is very infrequent, and they suggest that it is unadvisable to perform MII-pH testing on patients with a DBI <500 Ω on prior MII-esophageal manometry. If needed, pH only testing off acid-suppressing therapy may be more advisable in these patients.
More Related Videos
08:25Construction of a Wireless-Enabled Endoscopically Implantable Sensor for pH Monitoring with Zero-Bias Schottky Diode-based Receiver
Published on: August 27, 2021
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Gastroesophageal Reflux Disease
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology